about
Heart Rate Reduction With Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial InfarctionSystemic injection of AAV9 carrying a periostin promoter targets gene expression to a myofibroblast-like lineage in mouse hearts after reperfused myocardial infarction.Adenosine 2B Receptor Activation Reduces Myocardial Reperfusion Injury by Promoting Anti-Inflammatory Macrophages Differentiation via PI3K/Akt Pathway.A novel cardiac muscle-derived biomaterial reduces dyskinesia and postinfarct left ventricular remodeling in a mouse model of myocardial infarction.Adeno-associated virus serotype 9 efficiently targets ischemic skeletal muscle following systemic delivery.Systemic delivery of shRNA by AAV9 provides highly efficient knockdown of ubiquitously expressed GFP in mouse heart, but not liver.Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling.T₂ -weighted MRI of post-infarct myocardial edema in mice.Increased angiogenesis and improved left ventricular function after transplantation of myoblasts lacking the MyoD gene into infarcted myocardiumDistribution of AAV8 particles in cell lysates and culture media changes with time and is dependent on the recombinant vectorDevelopment and Optimization of AAV hFIX Particles by Transient Transfection in an iCELLis(®) Fixed-Bed Bioreactor.
P50
Q30276924-1EFE86A9-B545-4A77-A5A8-C45DBA954EA5Q30277247-7D865709-5D2A-44D1-A317-EF8D87818464Q30279041-4145D7D4-BC68-4EBB-AC20-8B2EA011B8BBQ30300274-0D3A1DFF-9C50-4601-8EFB-BE662464BD26Q30414524-0355AB63-3FA9-44A7-9506-F2C46AD50108Q30417032-93D02903-83A9-4ABC-9B2F-951E8C633D66Q30417445-17471C8D-6FCF-460E-90DB-F474A87617E9Q30423185-CA09BE1E-DA45-4309-8764-45ED7096D030Q34358919-BF2F6AF9-9918-45F6-B3F4-C5163F437B53Q39680091-FFDF8B7D-99DF-4225-AA2F-B84857F40E2DQ40733859-28B82F3A-1C6D-4017-ADD4-337236A89C15
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bryan A Piras
@ast
Bryan A Piras
@en
Bryan A Piras
@es
Bryan A Piras
@nl
type
label
Bryan A Piras
@ast
Bryan A Piras
@en
Bryan A Piras
@es
Bryan A Piras
@nl
prefLabel
Bryan A Piras
@ast
Bryan A Piras
@en
Bryan A Piras
@es
Bryan A Piras
@nl
P106
P31
P496
0000-0002-8352-2300